SIGNAL DETECTION USING DATA FROM FDA ADVERSE EVENT REPORTING SYSTEM (FAERS): INFECTIONS IN BIOLOGICS VS BIOSIMILARS

被引：0
|
作者：
Patel, U. [1 ]
Eguale, T. [1 ]
Rittenhouse, B. [2 ]
Yunusa, I [3 ]
Kandikatla, R. [4 ]
Fathima, A. [5 ]
机构：
[1] MCPHS Univ, Boston, MA USA
[2] MCPHS Univ, Winchester, MA USA
[3] Univ South Carolina, Columbia, SC 29208 USA
[4] MCPHS Univ, Malden, MA USA
[5] MCPHS Univ, Roxbury, MA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH146
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [41] Pharmacosurvellience Study of FDA Adverse Event Reporting System (FAERS) Events of Tofacitinib and Upadacitinib
    Barlas, Nur
    Barlas, Sait
    Milutinovic, Stefan
    Basnyat, Shristi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2058 - 2059
  • [42] Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)
    Timbrook, Tristan T.
    McKay, Lydia
    Sutton, Jesse D.
    Spivak, Emily S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [43] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Frei, Christopher R.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 23 - 29
  • [44] Comparative Safety of Dimethyl Fumarate and Fingolimod: Findings from the FDA Adverse Event Reporting System (FAERS)
    Roman, Cortnee
    Hersh, Carrie
    Sillau, Stefan
    Alvarez, Enrique
    NEUROLOGY, 2021, 96 (15)
  • [45] A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)
    He, Luyao
    Shen, Mengting
    Zhang, Lei
    Li, Yan
    Li, Huafang
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [46] Pharmacosurveillance study of FDA Adverse Event Reporting System (FAERS) events of Tirzepatide and Semaglutide
    Logvinsky, Ilana
    Barlas, Sait
    Maddineni, Gautam
    Wood, Malissa
    Delibasic, Maja
    CIRCULATION, 2024, 150
  • [47] Venetoclax and Tumor Lysis Syndrome (TLS): Data Mining of the FDA Adverse Event Reporting System (FAERS) Database
    Giorgio, C. D.
    Pascale, G.
    Cimarusti, C. C.
    Corru, F.
    Drago, D.
    Napoli, L.
    Ingrilli, S.
    Ruggiero, F.
    Cervi, L.
    DRUG SAFETY, 2022, 45 (10) : 1155 - 1156
  • [48] Medication overdose data analysis: a review of medication error reports in the FDA adverse event reporting system (FAERS)
    Ni, Jiaqi
    Tang, Xinru
    Chen, Li
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [49] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
  • [50] Romosozumab adverse event profile: a pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) from 2019 to 2023 Response
    Guldan, Mustafa
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2025, 37 (01)
12345